Review



rmlst scheme  (Clinical and Laboratory Standards Institute)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    Clinical and Laboratory Standards Institute rmlst scheme
    Rmlst Scheme, supplied by Clinical and Laboratory Standards Institute, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rmlst+scheme/rmlst+scheme/pm34896654-52-143-183
    Average 90 stars, based on 1 article reviews
    rmlst scheme - by Bioz Stars, 2026-09
    90/100 stars

    Images

    Related Articles

    Isolation:

    Article Title: First report of the mobile colistin resistance gene mcr-9.1 in Morganella morganii isolated from sewage in Georgia, USA.
    Article Snippet: This is important because IncF plasmids ( ∼50– 00 kb in size) have been associated with clinical strains of Enter- iety for Antimicrobial Chemotherapy. .. This is an open access article under the CC Table 1 Properties of the mcr-9.1- carrying Morganella morganii isolated from sewage in Georgia, USA Isolate identity a Origin Colistin MIC ( μg/mL) b ABR profile by disk diffusion c Intermediate resistance c Antibiotic susceptibility profile c ABR genes detected by WGS (ResFinder) d Additional ABR-associated genes detected by WGS (CARD) e Plasmids detected by WGS (PlasmidFinder) f Biofilm formation at 6 days (OD 570 ) g M. morganii Sewage influent > 640 AMP-AMC- ERY - GEN-KAN-STRTET-SXT-CHL IPM FEP-CTX-DOR- MEM-CIP-NOR aac(3)-IId; aph(3 ′ ′ )-Ib; aph(3 ′ )-Ia; aph(6)-Id; bla DHA-1 ; bla LAP-2 ; catA2; dfrA12; dfrA14; dfrA19; mcr-9.1; mph(A); qnrB2; qnrS1; sul1; sul2; tetA; tetB; tetD crp; qnrB20; aadA2; catII; rsmA IncFIB; IncFII 0.38 ± 0.07 MIC, minimum inhibitory concentration; ABR, antibiotic resistance; WGS, whole-genome sequencing. a Identity was determined using the ribosomal multilocus sequence typing (rMLST) scheme and species-specific PCR. b The colistin MIC was quantified by the broth microdilution method. c Resistance, intermediate resistance and susceptibility to antibiotics (other than colistin) was determined by the disk diffusion assay according to Clinical and Laboratory Standards Institute (CLSI) guidelines. ..

    Diffusion-based Assay:

    Article Title: First report of the mobile colistin resistance gene mcr-9.1 in Morganella morganii isolated from sewage in Georgia, USA.
    Article Snippet: This is important because IncF plasmids ( ∼50– 00 kb in size) have been associated with clinical strains of Enter- iety for Antimicrobial Chemotherapy. .. This is an open access article under the CC Table 1 Properties of the mcr-9.1- carrying Morganella morganii isolated from sewage in Georgia, USA Isolate identity a Origin Colistin MIC ( μg/mL) b ABR profile by disk diffusion c Intermediate resistance c Antibiotic susceptibility profile c ABR genes detected by WGS (ResFinder) d Additional ABR-associated genes detected by WGS (CARD) e Plasmids detected by WGS (PlasmidFinder) f Biofilm formation at 6 days (OD 570 ) g M. morganii Sewage influent > 640 AMP-AMC- ERY - GEN-KAN-STRTET-SXT-CHL IPM FEP-CTX-DOR- MEM-CIP-NOR aac(3)-IId; aph(3 ′ ′ )-Ib; aph(3 ′ )-Ia; aph(6)-Id; bla DHA-1 ; bla LAP-2 ; catA2; dfrA12; dfrA14; dfrA19; mcr-9.1; mph(A); qnrB2; qnrS1; sul1; sul2; tetA; tetB; tetD crp; qnrB20; aadA2; catII; rsmA IncFIB; IncFII 0.38 ± 0.07 MIC, minimum inhibitory concentration; ABR, antibiotic resistance; WGS, whole-genome sequencing. a Identity was determined using the ribosomal multilocus sequence typing (rMLST) scheme and species-specific PCR. b The colistin MIC was quantified by the broth microdilution method. c Resistance, intermediate resistance and susceptibility to antibiotics (other than colistin) was determined by the disk diffusion assay according to Clinical and Laboratory Standards Institute (CLSI) guidelines. ..

    Concentration Assay:

    Article Title: First report of the mobile colistin resistance gene mcr-9.1 in Morganella morganii isolated from sewage in Georgia, USA.
    Article Snippet: This is important because IncF plasmids ( ∼50– 00 kb in size) have been associated with clinical strains of Enter- iety for Antimicrobial Chemotherapy. .. This is an open access article under the CC Table 1 Properties of the mcr-9.1- carrying Morganella morganii isolated from sewage in Georgia, USA Isolate identity a Origin Colistin MIC ( μg/mL) b ABR profile by disk diffusion c Intermediate resistance c Antibiotic susceptibility profile c ABR genes detected by WGS (ResFinder) d Additional ABR-associated genes detected by WGS (CARD) e Plasmids detected by WGS (PlasmidFinder) f Biofilm formation at 6 days (OD 570 ) g M. morganii Sewage influent > 640 AMP-AMC- ERY - GEN-KAN-STRTET-SXT-CHL IPM FEP-CTX-DOR- MEM-CIP-NOR aac(3)-IId; aph(3 ′ ′ )-Ib; aph(3 ′ )-Ia; aph(6)-Id; bla DHA-1 ; bla LAP-2 ; catA2; dfrA12; dfrA14; dfrA19; mcr-9.1; mph(A); qnrB2; qnrS1; sul1; sul2; tetA; tetB; tetD crp; qnrB20; aadA2; catII; rsmA IncFIB; IncFII 0.38 ± 0.07 MIC, minimum inhibitory concentration; ABR, antibiotic resistance; WGS, whole-genome sequencing. a Identity was determined using the ribosomal multilocus sequence typing (rMLST) scheme and species-specific PCR. b The colistin MIC was quantified by the broth microdilution method. c Resistance, intermediate resistance and susceptibility to antibiotics (other than colistin) was determined by the disk diffusion assay according to Clinical and Laboratory Standards Institute (CLSI) guidelines. ..

    Sequencing:

    Article Title: First report of the mobile colistin resistance gene mcr-9.1 in Morganella morganii isolated from sewage in Georgia, USA.
    Article Snippet: This is important because IncF plasmids ( ∼50– 00 kb in size) have been associated with clinical strains of Enter- iety for Antimicrobial Chemotherapy. .. This is an open access article under the CC Table 1 Properties of the mcr-9.1- carrying Morganella morganii isolated from sewage in Georgia, USA Isolate identity a Origin Colistin MIC ( μg/mL) b ABR profile by disk diffusion c Intermediate resistance c Antibiotic susceptibility profile c ABR genes detected by WGS (ResFinder) d Additional ABR-associated genes detected by WGS (CARD) e Plasmids detected by WGS (PlasmidFinder) f Biofilm formation at 6 days (OD 570 ) g M. morganii Sewage influent > 640 AMP-AMC- ERY - GEN-KAN-STRTET-SXT-CHL IPM FEP-CTX-DOR- MEM-CIP-NOR aac(3)-IId; aph(3 ′ ′ )-Ib; aph(3 ′ )-Ia; aph(6)-Id; bla DHA-1 ; bla LAP-2 ; catA2; dfrA12; dfrA14; dfrA19; mcr-9.1; mph(A); qnrB2; qnrS1; sul1; sul2; tetA; tetB; tetD crp; qnrB20; aadA2; catII; rsmA IncFIB; IncFII 0.38 ± 0.07 MIC, minimum inhibitory concentration; ABR, antibiotic resistance; WGS, whole-genome sequencing. a Identity was determined using the ribosomal multilocus sequence typing (rMLST) scheme and species-specific PCR. b The colistin MIC was quantified by the broth microdilution method. c Resistance, intermediate resistance and susceptibility to antibiotics (other than colistin) was determined by the disk diffusion assay according to Clinical and Laboratory Standards Institute (CLSI) guidelines. ..

    Polymerase Chain Reaction:

    Article Title: First report of the mobile colistin resistance gene mcr-9.1 in Morganella morganii isolated from sewage in Georgia, USA.
    Article Snippet: This is important because IncF plasmids ( ∼50– 00 kb in size) have been associated with clinical strains of Enter- iety for Antimicrobial Chemotherapy. .. This is an open access article under the CC Table 1 Properties of the mcr-9.1- carrying Morganella morganii isolated from sewage in Georgia, USA Isolate identity a Origin Colistin MIC ( μg/mL) b ABR profile by disk diffusion c Intermediate resistance c Antibiotic susceptibility profile c ABR genes detected by WGS (ResFinder) d Additional ABR-associated genes detected by WGS (CARD) e Plasmids detected by WGS (PlasmidFinder) f Biofilm formation at 6 days (OD 570 ) g M. morganii Sewage influent > 640 AMP-AMC- ERY - GEN-KAN-STRTET-SXT-CHL IPM FEP-CTX-DOR- MEM-CIP-NOR aac(3)-IId; aph(3 ′ ′ )-Ib; aph(3 ′ )-Ia; aph(6)-Id; bla DHA-1 ; bla LAP-2 ; catA2; dfrA12; dfrA14; dfrA19; mcr-9.1; mph(A); qnrB2; qnrS1; sul1; sul2; tetA; tetB; tetD crp; qnrB20; aadA2; catII; rsmA IncFIB; IncFII 0.38 ± 0.07 MIC, minimum inhibitory concentration; ABR, antibiotic resistance; WGS, whole-genome sequencing. a Identity was determined using the ribosomal multilocus sequence typing (rMLST) scheme and species-specific PCR. b The colistin MIC was quantified by the broth microdilution method. c Resistance, intermediate resistance and susceptibility to antibiotics (other than colistin) was determined by the disk diffusion assay according to Clinical and Laboratory Standards Institute (CLSI) guidelines. ..



    Similar Products

    rmlst scheme  (Clinical and Laboratory Standards Institute)
    90
    Clinical and Laboratory Standards Institute rmlst scheme
    Rmlst Scheme, supplied by Clinical and Laboratory Standards Institute, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rmlst+scheme/rmlst+scheme/pm34896654-52-143-183
    Average 90 stars, based on 1 article reviews
    rmlst scheme - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier

    Image Search Results